TCTAP A-167 Bioabsorbable Vascular Scaffolds (BVS) Eluting with Everolimus: for Percutaneous Coronary Intervention (PCI) of Patients with De-novo Coronary Artery Lesion: Our Experiences at Apollo Hospitals Dhaka

TCTAP A-167 Bioabsorbable Vascular Scaffolds (BVS) Eluting with Everolimus: for Percutaneous Coronary Intervention (PCI) of Patients with De-novo Coronary Artery Lesion: Our Experiences at Apollo Hospitals Dhaka

Conclusion BVS absorb Everolimus eluting vascular scaffold showed favorable clinical outcome without any major cardiac events (acute or late stent thrombosis, MI or death) over a period of 9 month. [...]BVS absorb would be favorable alternative to other available drug eluting metallic stents.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-04, Vol.63 (12), p.S47-S48
Hauptverfasser: Munwar, Shams, Islam, Ahm Waliul, Talukder, Shahbudin, Reza, A.Q.M, Ahmed, Tamzeed, Bhuiyan, Azfar H, Masud, Rowsan, Siddique, Atique B
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Coronary vessels
Internal Medicine
Stents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conclusion BVS absorb Everolimus eluting vascular scaffold showed favorable clinical outcome without any major cardiac events (acute or late stent thrombosis, MI or death) over a period of 9 month. [...]BVS absorb would be favorable alternative to other available drug eluting metallic stents.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.02.202